Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
By leveraging historical analysis and forecast projections, this study offers a holistic understanding of market developments, assisting stakeholders in making informed strategic decisions. Additionally, a SWOT analysis is incorporated to highlight strengths, weaknesses, opportunities, and threats within the sector.
The evolving U.S. tariff policy in 2025 is bringing considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the world, assessing their impacts on Molecular Point-of-Care Testing market competitiveness, regional economic interdependencies, and supply chain reconfigurations.
Molecular Point-of-Care Testing Market Segmentation
Market segmentation in research is the process of breaking down a broad market into distinct consumer groups based on shared characteristics, such as demographics, geographic location, behavioral patterns, or lifestyle preferences. This approach enables businesses to refine their product offerings and marketing strategies to better address the unique needs of each segment. By tailoring their approach, companies can optimize resource allocation, enhance customer satisfaction, and drive sales growth, ultimately securing a competitive advantage. Effective segmentation helps businesses gain deeper insights into their audience, craft targeted strategies, and maximize overall market performance.
Molecular Point-of-Care Testing Market by Type [Analysis by Value from 2020 to ]:
- PCR-Based
- Isothermal Amplification
- CRISPR-Based
- Nucleic Acid Hybridization
Molecular Point-of-Care Testing Market by Application [Analysis by Value from 2020 to ]:
- Infectious Disease
- Cancer Screening
- Genetic Testing
- Drug Resistance
Key Players in the Molecular Point-of-Care Testing Market
Leading market players are focused on strengthening their presence by acquiring emerging companies. Established firms are heavily investing in research and development to introduce innovative products and expand their market reach. Additionally, some companies are engaging in mergers to leverage their combined strengths and deliver high-quality products. Based on these factors, the study includes the following key industry players.
- Abbott
- Roche
- BioFire Diagnostics
- Cepheid
- QuidelOrtho
- BD
- Hologic
- etc.
Molecular Point-of-Care Testing Market Dynamics: Drivers & Restraints
The report meticulously examines the core growth factors and challenges influencing market expansion. Each variable is supported by qualitative and quantitative insights, with Harvey ball indicators representing their level of impact.
Molecular Point-of-Care Testing Market Analysis & Industry Trends
A comprehensive overview of industry developments, regulatory updates, and structural market shifts is provided. The report also evaluates the impact of U.S. tariff policy on global demand fluctuations and recovery patterns.
Molecular Point-of-Care Testing Market Size & Demand Forecast ()
Precise market sizing data and demand forecasts are included, covering year-on-year (YoY) growth rates and compound annual growth rate (CAGR) projections, enabling businesses to plan for future growth.
Molecular Point-of-Care Testing Industry Supply Chain & Competitive Analysis
Using Porter’s Five Forces framework, the report assesses competitive intensity and profitability within the industry. A detailed supply chain analysis examines market participants, operational structures, and efficiency factors.
Molecular Point-of-Care Testing Segmentation & Growth Forecasts
The study systematically breaks down the Global Molecular Point-of-Care Testing Market into multiple segments, outlining current conditions and future growth trajectories. This helps identify emerging trends and lucrative opportunities.
Regional Market Insights
The report offers country-wise assessments of market drivers, regulatory frameworks, and growth prospects across key regions:
• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Russia)
• Asia-Pacific (China, India, Japan, South Korea, Australia)
• Rest of the World (Saudi Arabia, Brazil, Nigeria, South Africa)
Competitive Landscape & Key Player Profiles
Detailed evaluations of major companies include:
• Business overview & product offerings
• Financial performance & investment trends
• Recent mergers, acquisitions, and joint ventures (JVs)
• Strategic approaches adopted by market leaders
Executive Summary & Actionable Recommendations
A concise summary featuring charts, infographics, and forward-looking forecasts is provided. The report concludes with strategic recommendations to guide market stakeholders in decision-making.
Why Invest in This Molecular Point-of-Care Testing Market Report?
✔️ Gain valuable insights into how COVID-19 has influenced the Molecular Point-of-Care Testing market.
✔️ Discover market opportunities across key global regions.
✔️ Evaluate growth drivers & restraints and their long-term impact.
✔️ Access comprehensive market sizing & forecasting data.
✔️ Stay ahead of industry trends & competitive strategies.
✔️ Monitor M&A activities, partnerships, and joint ventures shaping the market.
For expert insights and customized segmentation, contact us to tailor the report to your specific business needs.
1 Market Overview
1.1 Product Overview and Scope of Molecular Point-of-Care Testing
1.2 Global Molecular Point-of-Care Testing Market Size and Forecast
1.3 China Molecular Point-of-Care Testing Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Molecular Point-of-Care Testing Share in Global Market, 2019-2030
1.4.2 Molecular Point-of-Care Testing Market Size: China VS Global, 2019-2030
1.5 Molecular Point-of-Care Testing Market Dynamics
1.5.1 Molecular Point-of-Care Testing Market Drivers
1.5.2 Molecular Point-of-Care Testing Market Restraints
1.5.3 Molecular Point-of-Care Testing Industry Trends
1.5.4 Molecular Point-of-Care Testing Industry Policy
2 Global Competitive Situation by Company
2.1 Global Molecular Point-of-Care Testing Revenue by Company (2019-2024)
2.2 Global Molecular Point-of-Care Testing Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Molecular Point-of-Care Testing Concentration Ratio
2.4 Global Molecular Point-of-Care Testing Mergers & Acquisitions, Expansion Plans
2.5 Global Molecular Point-of-Care Testing Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Molecular Point-of-Care Testing Revenue by Company (2019-2024)
3.2 China Molecular Point-of-Care Testing Molecular Point-of-Care Testing Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Molecular Point-of-Care Testing, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)
4 Industry Chain Analysis
4.1 Molecular Point-of-Care Testing Industry Chain
4.2 Molecular Point-of-Care Testing Upstream Analysis
4.3 Molecular Point-of-Care Testing Midstream Analysis
4.4 Molecular Point-of-Care Testing Downstream Analysis
5 Sights by Type
5.1 Molecular Point-of-Care Testing Classification
5.1.1 Polymerase Chain Reaction (PCR)
5.1.2 Loop-mediated Isothermal Amplification (LAMP)
5.1.3 Nucleic Acid Sequence-based Amplification (NASBA)
5.2 By Type, Global Molecular Point-of-Care Testing Market Size & CAGR, 2019 VS 2024 VS 2030
5.3 By Type, Global Molecular Point-of-Care Testing Revenue, 2019-2030
6 Sights by Application
6.1 Molecular Point-of-Care Testing Segment by Application
6.1.1 Infectious Diseases
6.1.2 Genetic Disorders
6.1.3 Pregnancy Testing
6.1.4 Diagnosis of Cancer
6.1.5 Pharmacogenomics
6.2 By Application, Global Molecular Point-of-Care Testing Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Application, Global Molecular Point-of-Care Testing Revenue, 2019-2030
7 Sales Sights by Region
7.1 By Region, Global Molecular Point-of-Care Testing Market Size, 2019 VS 2024 VS 2030
7.2 By Region, Global Molecular Point-of-Care Testing Market Size, 2019-2030
7.3 North America
7.3.1 North America Molecular Point-of-Care Testing Market Size & Forecasts, 2019-2030
7.3.2 By Country, North America Molecular Point-of-Care Testing Market Size Market Share
7.4 Europe
7.4.1 Europe Molecular Point-of-Care Testing Market Size & Forecasts, 2019-2030
7.4.2 By Country, Europe Molecular Point-of-Care Testing Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Molecular Point-of-Care Testing Market Size & Forecasts, 2019-2030
7.5.2 By Country/Region, Asia Pacific Molecular Point-of-Care Testing Market Size Market Share
7.6 South America
7.6.1 South America Molecular Point-of-Care Testing Market Size & Forecasts, 2019-2030
7.6.2 By Country, South America Molecular Point-of-Care Testing Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Molecular Point-of-Care Testing Market Size & CAGR,2019 VS 2024 VS 2030
8.2 By Country, Global Molecular Point-of-Care Testing Market Size, 2019-2030
8.3 U.S.
8.3.1 U.S. Molecular Point-of-Care Testing Market Size, 2019-2030
8.3.2 By Company, U.S. Molecular Point-of-Care Testing Revenue Market Share, 2019-2024
8.3.3 By Type, U.S. Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
8.3.4 By Application, U.S. Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
8.4 Europe
8.4.1 Europe Molecular Point-of-Care Testing Market Size, 2019-2030
8.4.2 By Company, Europe Molecular Point-of-Care Testing Revenue Market Share, 2019-2024
8.4.3 By Type, Europe Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
8.4.4 By Application, Europe Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
8.5 China
8.5.1 China Molecular Point-of-Care Testing Market Size, 2019-2030
8.5.2 By Company, China Molecular Point-of-Care Testing Revenue Market Share, 2019-2024
8.5.3 By Type, China Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
8.5.4 By Application, China Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
8.6 Japan
8.6.1 Japan Molecular Point-of-Care Testing Market Size, 2019-2030
8.6.2 By Company, Japan Molecular Point-of-Care Testing Revenue Market Share, 2019-2024
8.6.3 By Type, Japan Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
8.6.4 By Application, Japan Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
8.7 South Korea
8.7.1 South Korea Molecular Point-of-Care Testing Market Size, 2019-2030
8.7.2 By Company, South Korea Molecular Point-of-Care Testing Revenue Market Share, 2019-2024
8.7.3 By Type, South Korea Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
8.7.4 By Application, South Korea Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
8.8 Southeast Asia
8.8.1 Southeast Asia Molecular Point-of-Care Testing Market Size, 2019-2030
8.8.2 By Company, Southeast Asia Molecular Point-of-Care Testing Revenue Market Share, 2019-2024
8.8.3 By Type, Southeast Asia Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
8.8.4 By Application, Southeast Asia Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
8.9 India
8.9.1 India Molecular Point-of-Care Testing Market Size, 2019-2030
8.9.2 By Company, India Molecular Point-of-Care Testing Revenue Market Share, 2019-2024
8.9.3 By Type, India Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
8.9.4 By Application, India Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
8.10 Middle East & Asia
8.10.1 Middle East & Asia Molecular Point-of-Care Testing Market Size, 2019-2030
8.10.2 By Company, Middle East & Asia Molecular Point-of-Care Testing Revenue Market Share, 2019-2024
8.10.3 By Type, Middle East & Asia Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
8.10.4 By Application, Middle East & Asia Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
9 Global Manufacturers Profile
9.1 Roche Molecular Diagnostics
9.1.1 Roche Molecular Diagnostics Company Information, Head Office, Market Area and Industry Position
9.1.2 Roche Molecular Diagnostics Company Profile and Main Business
9.1.3 Roche Molecular Diagnostics Molecular Point-of-Care Testing Models, Specifications and Application
9.1.4 Roche Molecular Diagnostics Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
9.1.5 Roche Molecular Diagnostics Recent Developments
9.2 Salignostics
9.2.1 Salignostics Company Information, Head Office, Market Area and Industry Position
9.2.2 Salignostics Company Profile and Main Business
9.2.3 Salignostics Molecular Point-of-Care Testing Models, Specifications and Application
9.2.4 Salignostics Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
9.2.5 Salignostics Recent Developments
9.3 Saw Diagnostics
9.3.1 Saw Diagnostics Company Information, Head Office, Market Area and Industry Position
9.3.2 Saw Diagnostics Company Profile and Main Business
9.3.3 Saw Diagnostics Molecular Point-of-Care Testing Models, Specifications and Application
9.3.4 Saw Diagnostics Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
9.3.5 Saw Diagnostics Recent Developments
9.4 Siemens Healthineer
9.4.1 Siemens Healthineer Company Information, Head Office, Market Area and Industry Position
9.4.2 Siemens Healthineer Company Profile and Main Business
9.4.3 Siemens Healthineer Molecular Point-of-Care Testing Models, Specifications and Application
9.4.4 Siemens Healthineer Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
9.4.5 Siemens Healthineer Recent Developments
9.5 Sona Nanotech
9.5.1 Sona Nanotech Company Information, Head Office, Market Area and Industry Position
9.5.2 Sona Nanotech Company Profile and Main Business
9.5.3 Sona Nanotech Molecular Point-of-Care Testing Models, Specifications and Application
9.5.4 Sona Nanotech Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
9.5.5 Sona Nanotech Recent Developments
9.6 T2 Biosystems
9.6.1 T2 Biosystems Company Information, Head Office, Market Area and Industry Position
9.6.2 T2 Biosystems Company Profile and Main Business
9.6.3 T2 Biosystems Molecular Point-of-Care Testing Models, Specifications and Application
9.6.4 T2 Biosystems Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
9.6.5 T2 Biosystems Recent Developments
9.7 Talis Biomedical
9.7.1 Talis Biomedical Company Information, Head Office, Market Area and Industry Position
9.7.2 Talis Biomedical Company Profile and Main Business
9.7.3 Talis Biomedical Molecular Point-of-Care Testing Models, Specifications and Application
9.7.4 Talis Biomedical Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
9.7.5 Talis Biomedical Recent Developments
9.8 Thermo Fisher Scientific Inc.
9.8.1 Thermo Fisher Scientific Inc. Company Information, Head Office, Market Area and Industry Position
9.8.2 Thermo Fisher Scientific Inc. Company Profile and Main Business
9.8.3 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Models, Specifications and Application
9.8.4 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
9.8.5 Thermo Fisher Scientific Inc. Recent Developments
9.9 Veramarx
9.9.1 Veramarx Company Information, Head Office, Market Area and Industry Position
9.9.2 Veramarx Company Profile and Main Business
9.9.3 Veramarx Molecular Point-of-Care Testing Models, Specifications and Application
9.9.4 Veramarx Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
9.9.5 Veramarx Recent Developments
9.10 XCR Diagnostics
9.10.1 XCR Diagnostics Company Information, Head Office, Market Area and Industry Position
9.10.2 XCR Diagnostics Company Profile and Main Business
9.10.3 XCR Diagnostics Molecular Point-of-Care Testing Models, Specifications and Application
9.10.4 XCR Diagnostics Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
9.10.5 XCR Diagnostics Recent Developments
9.11 Zhejiang Orient Gene Biotech
9.11.1 Zhejiang Orient Gene Biotech Company Information, Head Office, Market Area and Industry Position
9.11.2 Zhejiang Orient Gene Biotech Company Profile and Main Business
9.11.3 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Models, Specifications and Application
9.11.4 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
9.11.5 Zhejiang Orient Gene Biotech Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Molecular Point-of-Care Testing Market Size & CAGR: China VS Global, (US$ Million), 2019-2030
Table 2. Molecular Point-of-Care Testing Market Restraints
Table 3. Molecular Point-of-Care Testing Market Trends
Table 4. Molecular Point-of-Care Testing Industry Policy
Table 5. Global Molecular Point-of-Care Testing Revenue by Company (2019-2024) & (US$ million)
Table 6. Global Molecular Point-of-Care Testing Revenue Market Share by Company (2019-2024)
Table 7. Global Molecular Point-of-Care Testing Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Molecular Point-of-Care Testing Mergers & Acquisitions, Expansion Plans
Table 9. Global Molecular Point-of-Care Testing Manufacturers Product Type
Table 10. China Molecular Point-of-Care Testing Revenue by Company (2019-2024) & (US$ million)
Table 11. China Molecular Point-of-Care Testing Revenue Market Share by Company (2019-2024)
Table 12. Global Key Players of Molecular Point-of-Care Testing Upstream (Raw Materials)
Table 13. Global Molecular Point-of-Care Testing Typical Customers
Table 14. Molecular Point-of-Care Testing Typical Distributors
Table 15. By Type, Global Molecular Point-of-Care Testing Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 16. By Application, Global Molecular Point-of-Care Testing Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 17. By Region, Global Molecular Point-of-Care Testing Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 18. By Region, Global Molecular Point-of-Care Testing Revenue, 2019-2030, US$ Million
Table 19. By Country, Global Molecular Point-of-Care Testing Revenue & CAGR,2019 VS 2024 VS 2030, US$ Million
Table 20. By Country, Global Molecular Point-of-Care Testing Revenue, 2019-2030, US$ Million
Table 21. By Country, Global Molecular Point-of-Care Testing Revenue Market Share, 2019-2030
Table 22. Roche Molecular Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 23. Roche Molecular Diagnostics Company Profile and Main Business
Table 24. Roche Molecular Diagnostics Molecular Point-of-Care Testing Models, Specifications and Application
Table 25. Roche Molecular Diagnostics Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
Table 26. Roche Molecular Diagnostics Recent Developments
Table 27. Salignostics Company Information, Head Office, Market Area and Industry Position
Table 28. Salignostics Company Profile and Main Business
Table 29. Salignostics Molecular Point-of-Care Testing Models, Specifications and Application
Table 30. Salignostics Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
Table 31. Salignostics Recent Developments
Table 32. Saw Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 33. Saw Diagnostics Company Profile and Main Business
Table 34. Saw Diagnostics Molecular Point-of-Care Testing Models, Specifications and Application
Table 35. Saw Diagnostics Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
Table 36. Saw Diagnostics Recent Developments
Table 37. Siemens Healthineer Company Information, Head Office, Market Area and Industry Position
Table 38. Siemens Healthineer Company Profile and Main Business
Table 39. Siemens Healthineer Molecular Point-of-Care Testing Models, Specifications and Application
Table 40. Siemens Healthineer Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
Table 41. Siemens Healthineer Recent Developments
Table 42. Sona Nanotech Company Information, Head Office, Market Area and Industry Position
Table 43. Sona Nanotech Company Profile and Main Business
Table 44. Sona Nanotech Molecular Point-of-Care Testing Models, Specifications and Application
Table 45. Sona Nanotech Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
Table 46. Sona Nanotech Recent Developments
Table 47. T2 Biosystems Company Information, Head Office, Market Area and Industry Position
Table 48. T2 Biosystems Company Profile and Main Business
Table 49. T2 Biosystems Molecular Point-of-Care Testing Models, Specifications and Application
Table 50. T2 Biosystems Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
Table 51. T2 Biosystems Recent Developments
Table 52. Talis Biomedical Company Information, Head Office, Market Area and Industry Position
Table 53. Talis Biomedical Company Profile and Main Business
Table 54. Talis Biomedical Molecular Point-of-Care Testing Models, Specifications and Application
Table 55. Talis Biomedical Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
Table 56. Talis Biomedical Recent Developments
Table 57. Thermo Fisher Scientific Inc. Company Information, Head Office, Market Area and Industry Position
Table 58. Thermo Fisher Scientific Inc. Company Profile and Main Business
Table 59. Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Models, Specifications and Application
Table 60. Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
Table 61. Thermo Fisher Scientific Inc. Recent Developments
Table 62. Veramarx Company Information, Head Office, Market Area and Industry Position
Table 63. Veramarx Company Profile and Main Business
Table 64. Veramarx Molecular Point-of-Care Testing Models, Specifications and Application
Table 65. Veramarx Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
Table 66. Veramarx Recent Developments
Table 67. XCR Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 68. XCR Diagnostics Company Profile and Main Business
Table 69. XCR Diagnostics Molecular Point-of-Care Testing Models, Specifications and Application
Table 70. XCR Diagnostics Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
Table 71. XCR Diagnostics Recent Developments
Table 72. Zhejiang Orient Gene Biotech Company Information, Head Office, Market Area and Industry Position
Table 73. Zhejiang Orient Gene Biotech Company Profile and Main Business
Table 74. Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Models, Specifications and Application
Table 75. Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Revenue and Gross Margin, 2019-2024
Table 76. Zhejiang Orient Gene Biotech Recent Developments
List of Figure
Figure 1. Molecular Point-of-Care Testing Picture
Figure 2. Global Molecular Point-of-Care Testing Industry Market Size and Forecast (US$ million) & (2019-2030)
Figure 3. China Molecular Point-of-Care Testing Revenue and Forecast (US$ million) & (2019-2030)
Figure 4. 2019-2030 China Molecular Point-of-Care Testing Market Share of Global
Figure 5. Global Molecular Point-of-Care Testing Key Participants, Market Share, 2021 VS 2024 VS 2024
Figure 6. Global Molecular Point-of-Care Testing Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024
Figure 7. China Molecular Point-of-Care Testing Key Participants, Market Share, 2021 VS 2024 VS 2024
Figure 8. China Molecular Point-of-Care Testing Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 9. Molecular Point-of-Care Testing Industry Chain
Figure 10. Polymerase Chain Reaction (PCR)
Figure 11. Loop-mediated Isothermal Amplification (LAMP)
Figure 12. Nucleic Acid Sequence-based Amplification (NASBA)
Figure 13. By Type, Global Molecular Point-of-Care Testing Revenue, 2019-2030, US$ Million
Figure 14. By Type, Global Molecular Point-of-Care Testing Revenue Market Share, 2019-2030
Figure 15. Infectious Diseases
Figure 16. Genetic Disorders
Figure 17. Pregnancy Testing
Figure 18. Diagnosis of Cancer
Figure 19. Pharmacogenomics
Figure 20. By Application, Global Molecular Point-of-Care Testing Revenue, 2019-2030, US$ Million
Figure 21. By Application, Global Molecular Point-of-Care Testing Revenue Market Share, 2019-2030
Figure 22. By Region, Global Molecular Point-of-Care Testing Revenue Market Share, 2019-2030
Figure 23. North America Molecular Point-of-Care Testing Revenue & Forecasts, 2019-2030, US$ Million
Figure 24. By Country, North America Molecular Point-of-Care Testing Revenue Market Share, 2019-2024
Figure 25. Europe Molecular Point-of-Care Testing Revenue & Forecasts, 2019-2030, US$ Million
Figure 26. By Country, Europe Molecular Point-of-Care Testing Revenue Market Share, 2019-2024
Figure 27. Asia Pacific Molecular Point-of-Care Testing Revenue & Forecasts, 2019-2030, US$ Million
Figure 28. By Country/Region, Asia Pacific Molecular Point-of-Care Testing Revenue Market Share, 2019-2024
Figure 29. South America Molecular Point-of-Care Testing Revenue & Forecasts, 2019-2030, US$ Million
Figure 30. By Country, South America Molecular Point-of-Care Testing Revenue Market Share, 2019-2024
Figure 31. Middle East & Africa Molecular Point-of-Care Testing Revenue & Forecasts, 2019-2030, US$ Million
Figure 32. U.S. Molecular Point-of-Care Testing Revenue, 2019-2030, (US$ Million)
Figure 33. By Company, U.S. Molecular Point-of-Care Testing Market Share, 2019-2024
Figure 34. By Type, U.S. Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
Figure 35. By Application, U.S. Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
Figure 36. Europe Molecular Point-of-Care Testing Revenue, 2019-2030, (US$ Million)
Figure 37. By Company, Europe Molecular Point-of-Care Testing Market Share, 2019-2024
Figure 38. By Type, Europe Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
Figure 39. By Application, Europe Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
Figure 40. China Molecular Point-of-Care Testing Revenue, 2019-2030, (US$ Million)
Figure 41. By Company, China Molecular Point-of-Care Testing Market Share, 2019-2024
Figure 42. By Type, China Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
Figure 43. By Application, China Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
Figure 44. Japan Molecular Point-of-Care Testing Revenue, 2019-2030, (US$ Million)
Figure 45. By Company, Japan Molecular Point-of-Care Testing Market Share, 2019-2024
Figure 46. By Type, Japan Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
Figure 47. By Application, Japan Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
Figure 48. South Korea Molecular Point-of-Care Testing Revenue, 2019-2030, (US$ Million)
Figure 49. By Company, South Korea Molecular Point-of-Care Testing Market Share, 2019-2024
Figure 50. By Type, South Korea Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
Figure 51. By Application, South Korea Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
Figure 52. Southeast Asia Molecular Point-of-Care Testing Revenue, 2019-2030, (US$ Million)
Figure 53. By Company, Southeast Asia Molecular Point-of-Care Testing Market Share, 2019-2024
Figure 54. By Type, Southeast Asia Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
Figure 55. By Application, Southeast Asia Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
Figure 56. India Molecular Point-of-Care Testing Revenue, 2019-2030, (US$ Million)
Figure 57. By Company, India Molecular Point-of-Care Testing Market Share, 2019-2024
Figure 58. By Type, India Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
Figure 59. By Application, India Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
Figure 60. Middle East & Asia Molecular Point-of-Care Testing Revenue, 2019-2030, (US$ Million)
Figure 61. By Company, Middle East & Asia Molecular Point-of-Care Testing Market Share, 2019-2024
Figure 62. By Type, Middle East & Asia Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
Figure 63. By Application, Middle East & Asia Molecular Point-of-Care Testing Revenue Market Share, 2024 VS 2030
Figure 64. Research Methodology
Figure 65. Breakdown of Primary Interviews
Figure 66. Bottom-up Approaches
Figure 67. Top-down Approaches
Research Methodology:
Molecular Point-of-Care Testing Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|